1. Home
  2. MGLD vs TVGN Comparison

MGLD vs TVGN Comparison

Compare MGLD & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • TVGN
  • Stock Information
  • Founded
  • MGLD 1996
  • TVGN 2020
  • Country
  • MGLD United States
  • TVGN United States
  • Employees
  • MGLD N/A
  • TVGN N/A
  • Industry
  • MGLD Finance/Investors Services
  • TVGN Blank Checks
  • Sector
  • MGLD Finance
  • TVGN Finance
  • Exchange
  • MGLD Nasdaq
  • TVGN Nasdaq
  • Market Cap
  • MGLD 60.7M
  • TVGN 53.6M
  • IPO Year
  • MGLD N/A
  • TVGN N/A
  • Fundamental
  • Price
  • MGLD $1.34
  • TVGN $1.51
  • Analyst Decision
  • MGLD
  • TVGN
  • Analyst Count
  • MGLD 0
  • TVGN 0
  • Target Price
  • MGLD N/A
  • TVGN N/A
  • AVG Volume (30 Days)
  • MGLD 2.6K
  • TVGN 20.4M
  • Earning Date
  • MGLD 11-19-2024
  • TVGN 11-20-2024
  • Dividend Yield
  • MGLD N/A
  • TVGN N/A
  • EPS Growth
  • MGLD N/A
  • TVGN N/A
  • EPS
  • MGLD N/A
  • TVGN N/A
  • Revenue
  • MGLD $32,511,000.00
  • TVGN N/A
  • Revenue This Year
  • MGLD N/A
  • TVGN N/A
  • Revenue Next Year
  • MGLD N/A
  • TVGN N/A
  • P/E Ratio
  • MGLD N/A
  • TVGN N/A
  • Revenue Growth
  • MGLD N/A
  • TVGN N/A
  • 52 Week Low
  • MGLD $0.78
  • TVGN $0.26
  • 52 Week High
  • MGLD $1.92
  • TVGN $21.09
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 51.79
  • TVGN 52.48
  • Support Level
  • MGLD $1.15
  • TVGN $1.01
  • Resistance Level
  • MGLD $1.47
  • TVGN $1.91
  • Average True Range (ATR)
  • MGLD 0.08
  • TVGN 0.36
  • MACD
  • MGLD 0.01
  • TVGN -0.10
  • Stochastic Oscillator
  • MGLD 63.89
  • TVGN 37.11

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About TVGN Tevogen Bio Holdings Inc. Common Stock

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: